Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report

Abstract Background Autosomal recessive limb–girdle muscular dystrophy-1 (LGMDR1), also known as calpainopathy, is a genetically heterogeneous disorder characterised by progression of muscle weakness. Homozygous or compound heterozygous variants in the CAPN3 gene are known genetic causes of this con...

Full description

Bibliographic Details
Main Authors: Evelina Siavrienė, Gunda Petraitytė, Birutė Burnytė, Aušra Morkūnienė, Violeta Mikštienė, Tautvydas Rančelis, Algirdas Utkus, Vaidutis Kučinskas, Eglė Preikšaitienė
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-021-04920-3
_version_ 1818721615485075456
author Evelina Siavrienė
Gunda Petraitytė
Birutė Burnytė
Aušra Morkūnienė
Violeta Mikštienė
Tautvydas Rančelis
Algirdas Utkus
Vaidutis Kučinskas
Eglė Preikšaitienė
author_facet Evelina Siavrienė
Gunda Petraitytė
Birutė Burnytė
Aušra Morkūnienė
Violeta Mikštienė
Tautvydas Rančelis
Algirdas Utkus
Vaidutis Kučinskas
Eglė Preikšaitienė
author_sort Evelina Siavrienė
collection DOAJ
description Abstract Background Autosomal recessive limb–girdle muscular dystrophy-1 (LGMDR1), also known as calpainopathy, is a genetically heterogeneous disorder characterised by progression of muscle weakness. Homozygous or compound heterozygous variants in the CAPN3 gene are known genetic causes of this condition. The aim of this study was to confirm the molecular consequences of the CAPN3 variant NG_008660.1(NM_000070.3):c.1746-20C > G of an individual with suspected LGMDR1 by extensive complementary DNA (cDNA) analysis. Case presentation In the present study, we report on a male with proximal muscular weakness in his lower limbs. Compound heterozygous NM_000070.3:c.598_612del and NG_008660.1(NM_000070.3):c.1746-20C > G genotype was detected on the CAPN3 gene by targeted next-generation sequencing (NGS). To confirm the pathogenicity of the variant c.1746-20C > G, we conducted genetic analysis based on Sanger sequencing of the proband’s cDNA sample. The results revealed that this splicing variant disrupts the original 3′ splice site on intron 13, thus leading to the skipping of the DNA fragment involving exon 14 and possibly exon 15. However, the lack of exon 15 in the CAPN3 isoforms present in a blood sample was explained by cell-specific alternative splicing rather than an aberrant splicing mechanism. In silico the c.1746-20C > G splicing variant consequently resulted in frameshift and formation of a premature termination codon (NP_000061.1:p.(Glu582Aspfs*62)). Conclusions Based on the results of our study and the literature we reviewed, both c.598_612del and c.1746-20C > G variants are pathogenic and together cause LGMDR1. Therefore, extensive mRNA and/or cDNA analysis of splicing variants is critical to understand the pathogenesis of the disease.
first_indexed 2024-12-17T20:41:33Z
format Article
id doaj.art-9fa109b82e7f4d818b1ad473453435d8
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-12-17T20:41:33Z
publishDate 2021-12-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-9fa109b82e7f4d818b1ad473453435d82022-12-21T21:33:18ZengBMCBMC Musculoskeletal Disorders1471-24742021-12-012211810.1186/s12891-021-04920-3Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case reportEvelina Siavrienė0Gunda Petraitytė1Birutė Burnytė2Aušra Morkūnienė3Violeta Mikštienė4Tautvydas Rančelis5Algirdas Utkus6Vaidutis Kučinskas7Eglė Preikšaitienė8Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityBiobank of Lithuanian Population and Rare Disorders, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius UniversityAbstract Background Autosomal recessive limb–girdle muscular dystrophy-1 (LGMDR1), also known as calpainopathy, is a genetically heterogeneous disorder characterised by progression of muscle weakness. Homozygous or compound heterozygous variants in the CAPN3 gene are known genetic causes of this condition. The aim of this study was to confirm the molecular consequences of the CAPN3 variant NG_008660.1(NM_000070.3):c.1746-20C > G of an individual with suspected LGMDR1 by extensive complementary DNA (cDNA) analysis. Case presentation In the present study, we report on a male with proximal muscular weakness in his lower limbs. Compound heterozygous NM_000070.3:c.598_612del and NG_008660.1(NM_000070.3):c.1746-20C > G genotype was detected on the CAPN3 gene by targeted next-generation sequencing (NGS). To confirm the pathogenicity of the variant c.1746-20C > G, we conducted genetic analysis based on Sanger sequencing of the proband’s cDNA sample. The results revealed that this splicing variant disrupts the original 3′ splice site on intron 13, thus leading to the skipping of the DNA fragment involving exon 14 and possibly exon 15. However, the lack of exon 15 in the CAPN3 isoforms present in a blood sample was explained by cell-specific alternative splicing rather than an aberrant splicing mechanism. In silico the c.1746-20C > G splicing variant consequently resulted in frameshift and formation of a premature termination codon (NP_000061.1:p.(Glu582Aspfs*62)). Conclusions Based on the results of our study and the literature we reviewed, both c.598_612del and c.1746-20C > G variants are pathogenic and together cause LGMDR1. Therefore, extensive mRNA and/or cDNA analysis of splicing variants is critical to understand the pathogenesis of the disease.https://doi.org/10.1186/s12891-021-04920-3CAPN3LGMDR1cDNA assaySplicing variantCompound heterozygosity
spellingShingle Evelina Siavrienė
Gunda Petraitytė
Birutė Burnytė
Aušra Morkūnienė
Violeta Mikštienė
Tautvydas Rančelis
Algirdas Utkus
Vaidutis Kučinskas
Eglė Preikšaitienė
Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
BMC Musculoskeletal Disorders
CAPN3
LGMDR1
cDNA assay
Splicing variant
Compound heterozygosity
title Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
title_full Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
title_fullStr Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
title_full_unstemmed Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
title_short Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report
title_sort compound heterozygous c 598 612del and c 1746 20c g capn3 genotype cause autosomal recessive limb girdle muscular dystrophy 1 a case report
topic CAPN3
LGMDR1
cDNA assay
Splicing variant
Compound heterozygosity
url https://doi.org/10.1186/s12891-021-04920-3
work_keys_str_mv AT evelinasiavriene compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT gundapetraityte compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT biruteburnyte compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT ausramorkuniene compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT violetamikstiene compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT tautvydasrancelis compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT algirdasutkus compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT vaidutiskucinskas compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport
AT eglepreiksaitiene compoundheterozygousc598612delandc174620cgcapn3genotypecauseautosomalrecessivelimbgirdlemusculardystrophy1acasereport